Aviance Capital Partners LLC Has $5.37 Million Holdings in UnitedHealth Group Incorporated $UNH

Aviance Capital Partners LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 16,274 shares of the healthcare conglomerate’s stock after acquiring an additional 1,707 shares during the period. Aviance Capital Partners LLC’s holdings in UnitedHealth Group were worth $5,372,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Maj Invest Holding A S boosted its position in shares of UnitedHealth Group by 38.3% during the fourth quarter. Maj Invest Holding A S now owns 307 shares of the healthcare conglomerate’s stock valued at $101,000 after buying an additional 85 shares during the last quarter. Capstone Capital Management Ltd bought a new stake in UnitedHealth Group during the fourth quarter worth $330,000. Profund Advisors LLC lifted its holdings in UnitedHealth Group by 19.3% during the fourth quarter. Profund Advisors LLC now owns 18,792 shares of the healthcare conglomerate’s stock worth $6,203,000 after acquiring an additional 3,044 shares during the period. ProShare Advisors LLC lifted its holdings in UnitedHealth Group by 12.8% during the fourth quarter. ProShare Advisors LLC now owns 291,895 shares of the healthcare conglomerate’s stock worth $96,357,000 after acquiring an additional 33,173 shares during the period. Finally, Synergy Investment Management LLC lifted its holdings in UnitedHealth Group by 10.1% during the fourth quarter. Synergy Investment Management LLC now owns 2,076 shares of the healthcare conglomerate’s stock worth $685,000 after acquiring an additional 190 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 0.28% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. Royal Bank Of Canada boosted their target price on UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Wells Fargo & Company boosted their target price on UnitedHealth Group from $370.00 to $397.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. Robert W. Baird boosted their target price on UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a research note on Wednesday, April 22nd. Morgan Stanley boosted their price objective on UnitedHealth Group from $375.00 to $395.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. Finally, UBS Group decreased their price objective on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. One research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $381.83.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Negative Sentiment: Berkshire Hathaway’s full exit from UnitedHealth Group has weighed on sentiment, as the loss of a respected long-term investor may prompt other holders to reassess their positions. Reuters: UnitedHealth falls after Berkshire sells stake in health insurer
• Neutral Sentiment: UNH had been on a strong rebound before the Berkshire news, and recent earnings showed a profit beat and a guidance increase, suggesting the business recovery narrative is still intact. Yahoo Finance: UnitedHealth Group (UNH) Fell 33% as Rising Medical Costs and Member Mix Pressured Earnings
• Neutral Sentiment: A proposed healthcare bill focused on HSAs, price transparency, and expanded access to coverage could affect insurers over time, but it is still early and its stock impact is uncertain. Quiver Quantitative: New Bill H.R. 8324

UnitedHealth Group Price Performance

UNH opened at $390.44 on Tuesday. The stock has a 50-day moving average price of $318.85 and a 200-day moving average price of $318.35. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $404.15. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $354.57 billion, a P/E ratio of 29.49, a PEG ratio of 1.70 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. During the same period in the prior year, the business earned $7.20 EPS. The company’s revenue for the quarter was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is 66.77%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.